Crucially, scientists found no blood clot issues in study participants.
The findings shore up statements released by reputable health bodies, such as the UK’s drug regulator MHRA.
For the study, researchers recruited 32,449 participants in the US, Chile and Peru – 20,000 of whom were given the vaccine, with the rest given dummy jabs.
READ RELATED: COVID-19 is THE leading cause of death in the U.S., study finds
Other encouraging findings came to light too. Researchers found the vaccine was effective in all ages, including the over 65s.
READ MORE: Coronavirus new strain: Five signs you have a COVID-19 headache – ‘pulsing, stabbing’
Source: Daily Express
